The iconic rise of Viagra has long been a example of pharmaceutical success, yet its future within the broader sector now presents questions about potential returns . Copycat versions are eroding patent protection , prompting concerns that betting on companies heavily reliant to Viagra's previous influence could be a dangerous strategy, especially